News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Collegium trades at roughly 2.3x free cash flow.
  • Collegium's $650 million acquisition expands its ADHD exposure.
  • A modest guidance trim has pressured the stock.
  • Analyst says the balance sheet and free cash flow profile support a re-rate.
  • Recommended trade: buy $23.20, stop $20.50, target $40.00, 180-trading-day horizon.

Latest Articles

Ligand (LGND): Buy a Royalty Highway Through Biotech

Ligand (LGND): Buy a Royalty Highway Through Biotech

Ligand Pharmaceuticals offers a diversified way to own the upside of multiple drug programs without the binary risk of a single clinical asset. The company is trading on a mid-to-high valuation today, but accelerating royalty revenue, a string of investor events and elevated short interest create a tactical long opportunity for patient traders.

XORTX Announces Planned FDA IND Submission for XRx-026 Gout Program Using XORLO™, Targeting USD$700M+ U.S. Gout Market Opportunity

XORTX Announces Planned FDA IND Submission for XRx-026 Gout Program Using XORLO™, Targeting USD$700M+ U.S. Gout Market Opportunity

XORTX Therapeutics Inc. announced plans to submit an Investigational New Drug (IND) application to the FDA for its XRx-026 program, developing XORLO™, a proprietary formulation of oxypurinol for gout treatment. The company aims to file a New Drug Application (NDA) following a two-part clinical trial, targeting marketing approval to provide an alter…

PMGC Holdings Inc. (Nasdaq: ELAB) Secures Five-Year Royalty Stream from Elevai Skincare Sale Under Executed Payment Agreement with Longevity Health Holdings

PMGC Holdings Inc. (Nasdaq: ELAB) Secures Five-Year Royalty Stream from Elevai Skincare Sale Under Executed Payment Agreement with Longevity Health Holdings

PMGC Holdings Inc. has executed a binding, interest-bearing payment agreement with Longevity Health Holdings, securing a five-year royalty stream from the sale of its Elevai Skincare business. This agreement converts a 5% net sales royalty into scheduled monthly cash payments starting October 2026 through August 2031, creating a recurring, non-dilu…

Aura Minerals Announces USD 200 Million Syndicated Loan Facility

Aura Minerals Announces USD 200 Million Syndicated Loan Facility

Aura Minerals Inc. has announced a $200 million syndicated loan facility with Citigroup and Itaú BBA as lead arrangers. The loan, bearing interest at SOFR + 2.70%, includes a two-year grace period and five-year maturity. Funds will be used to finance supplier payments and prepay production costs as the company aims to increase gold equivalent ounce…

Gold.com Announces CFO & Auditor Transitions

Gold.com Announces CFO & Auditor Transitions

Gold.com announces the appointment of Jill Van as Chief Financial Officer effective September 18, 2026, succeeding Cary Dickson who is retiring. The company also selects KPMG LLP as its independent registered public accounting firm for the fiscal year ending June 30, 2027, succeeding Grant Thornton LLP. These leadership and auditor changes reflect …

Foresight Automotive Expands its Technological Scope into Full Autonomous Driving Solutions for Unmanned Ground and Aerial Vehicles and Appoints New CTO to Lead the Field

Foresight Automotive Expands its Technological Scope into Full Autonomous Driving Solutions for Unmanned Ground and Aerial Vehicles and Appoints New CTO to Lead the Field

Foresight Autonomous Holdings unveils a strategic expansion into full autonomous driving solutions targeting unmanned ground and aerial vehicles with a focus on off-road applications including defense, agriculture, and heavy machinery. The company appointed Shlomo Hillel as new CTO to spearhead this initiative. The autonomous kit integrating 3D per…

3 E Network Details Embodied AI Infrastructure and Completes Hardware Emulation for Custom Edge AI SoC

3 E Network Details Embodied AI Infrastructure and Completes Hardware Emulation for Custom Edge AI SoC

3 E Network Technology Group Limited announced its foundational system architecture for Embodied AI and advanced robotics infrastructure, emphasizing an 'Edge-Cloud Continuum' to optimize resource allocation between edge devices and cloud platforms. The company completed high-precision hardware emulation for its custom Edge AI System on Chip (SoC) …

Solventum Spin-Off: A Divestiture That Could Reprice the Stock

Solventum Spin-Off: A Divestiture That Could Reprice the Stock

Solventum appears set to unlock shareholder value by divesting a non-core industrial-solvent unit into a standalone company. The market has likely underappreciated the potential re-rating from a clean balance sheet, clearer growth profile, and a transactional catalyst. We lay out a mid-term trade to capture that revaluation: entry at $12.50, target…

Portillo’s Celebrates National Cheeseburger Day with Plans for a New Restaurant in Buford, Georgia

Portillo’s Celebrates National Cheeseburger Day with Plans for a New Restaurant in Buford, Georgia

Portillo's, a Chicago-based fast-casual restaurant chain known for its Chicago-style street food, revealed plans to open a new location in Buford, Georgia in 2027. This marks their second establishment in Georgia, following their 2025 Kennesaw opening. The new restaurant will feature indoor and outdoor seating, double drive-thru lanes, and convenie…

Beneficient Announces Upcoming Launch of AltLens, an Alternative Asset Portfolio Analytics and Risk Platform for Family Offices and Small Institutional Investors

Beneficient Announces Upcoming Launch of AltLens, an Alternative Asset Portfolio Analytics and Risk Platform for Family Offices and Small Institutional Investors

Beneficient announced the upcoming launch of AltLens, an alternative asset portfolio analytics and risk platform designed specifically for family offices and small institutional investors. Scheduled for release in Q4 2026, AltLens aims to provide sophisticated risk and concentration analyses by applying historical private market data and stress-tes…

Ready Capital Corporation Prices $225 Million of Senior Secured Notes Due 2031 and Announces Redemption of $350 Million of Notes Due 2026

Ready Capital Corporation Prices $225 Million of Senior Secured Notes Due 2031 and Announces Redemption of $350 Million of Notes Due 2026

Ready Capital Corporation has priced a $225 million private placement of 10% Senior Secured Notes due 2031 and announced the redemption of $350 million of 4.5% Senior Secured Notes due 2026. This transaction is part of the company's balance sheet repositioning program to reduce debt maturing in 2026 by replacing it with longer-term financing, there…

Abeona Therapeutics® Congratulates Ultragenyx on U.S. FDA Approval of FAYUVI™ Gene Therapy for Sanfilippo Syndrome Type A (MPS IIIA)

Abeona Therapeutics® Congratulates Ultragenyx on U.S. FDA Approval of FAYUVI™ Gene Therapy for Sanfilippo Syndrome Type A (MPS IIIA)

Abeona Therapeutics congratulates Ultragenyx on FDA approval of FAYUVI (UX111), a gene therapy originally developed by Abeona for Sanfilippo syndrome type A (MPS IIIA). Abeona out-licensed the product to Ultragenyx in 2022 and is eligible for milestone and royalty payments. The approval represents a significant advancement for patients with this ra…